This test analyzes key genes associated with Primary Hyperoxaluria using advanced Next-Generation Sequencing (NGS) on EDTA blood. It helps identify inherited mutations that cause excessive oxalate production leading to kidney stones and renal complications. Metropolis Healthcare performs this evaluation with high-precision genetic technology. The results support early diagnosis, treatment planning, and family counseling.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0242
Frequently Asked Questions (FAQ's):
What does the Primary Hyperoxaluria Gene Panel by NGS include?
This panel at Metropolis Healthcare examines major genes responsible for Primary Hyperoxaluria to detect disease-causing variants.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-depth NGS technology to sequence relevant genes and accurately identify pathogenic mutations.
Who should undergo this test?
Individuals with recurrent kidney stones, nephrocalcinosis, unexplained renal issues, or a family history of Primary Hyperoxaluria may benefit from testing at Metropolis Healthcare.
Why is genetic testing important for Primary Hyperoxaluria?
Metropolis Healthcare’s genetic analysis helps confirm diagnosis, guide treatment, and support prognosis evaluation.
Is a blood sample required for this test?
Yes, Metropolis Healthcare performs the test using an EDTA blood sample for reliable DNA extraction.
Can this test help with family planning?
Yes, Metropolis Healthcare’s results can assist families in understanding inheritance patterns and making informed decisions.
How long does it take to receive the results?
Turnaround times vary, but Metropolis Healthcare provides reports promptly after comprehensive analysis.
Do I need a doctor’s prescription for this test?
A prescription is generally recommended, and Metropolis Healthcare can guide you on pre-test requirements